• #LGM Pharma is a Metronidazole CAS# 443-48-1 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 443-48-1
  • AHFC code: 84:04.92, 84:04.04, 08:30.92
  • Synonyms: 1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole, 1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole, 1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole, 1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole, 1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole, 2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole, 2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole, 2-Methyl-5-nitroimidazole-1-ethanol, 5-23-05-00063 (Beilstein Handbook Reference), Acromona, Anagiardil, Arilin, Atrivyl, Bayer 5360, Bexon, BRN 0611683, Caswell No. 579AA, CCRIS 410, Clont, CONT, Danizol, Deflamon, Deflamon-wirkstoff, Efloran, EINECS 207-136-1, Elyzol, Entizol, EPA Pesticide Chemical Code 120401, Eumin, Flagemona, Flagesol, Flagil, Flagyl, Flagyl ER, Flagyl I.V. rtu in plastic container, Fossyol, Giatricol, Gineflavir, HSDB 3129, Klion, Klont, Meronidal, Metro Gel, Metro I.V., Metro I.V. in plastic container, Metrocream, Metrogel, MetroGel-Vaginal, Metrolotion, Metromidol, Metronidaz, Metronidazol, Metronidazol [INN-Spanish], Metronidazole, Metronidazole in plastic container, Metronidazolo, Metronidazolo [DCIT], Metronidazolum, Metronidazolum [INN-Latin], Mexibol, Mexibol 'silanes', Monagyl, Monasin, Nalox, Neo-tric, NIDA, Noritate, Novonidazol, NSC 50364, NSC 69587, NSC-50364, Orvagil, Protostat, RP 8823, Sanatrichom, Satric, SC 10295, Takimetol, Trichazol, Trichex, Trichocide, Trichomol, Trichomonacid 'pharmachim', Trichopol, Tricocet, Tricom, Tricowas B, Trikacide, Trikamon, Trikojol, Trikozol, Trimeks, Trivazol, UNII-140QMO216E, Vagilen, Vagimid, Vandazole, Vertisal, Wagitran
  • ATC Code: A01AB17" D06BX01" G01AF01" J01XD01" P01AB01
  • Chemical Formula: C6H9N3O3
  • Molecular Weight: 171.154
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB00916 (APRD00631)
  • SMILES: CC1=NC=C(N1CCO)[N+]([O-])=O
  • InChl: InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3
  • PubChem: 4173
  • IUPAC: 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethan-1-ol

Additional Details

Indication:
For the treatment of anaerobic infections and mixed infections, surgical prophylaxis requiring anaerobic coverage, Clostridium difficile-associated diarrhea and colitis, Helicobacter pylori infection and duodenal ulcer disease, bacterial vaginosis, Giardia lamblia gastro-enteritis, amebiasis caused by Entamoeba histolytica, acne rosacea (topical treatment), and Trichomonas infections.
Pharmacodynamics:
Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is used against protozoa such as Trichomonas vaginalis, amebiasis, and giardiasis. Metronidazole is extremely effective against anaerobic bacterial infections and is also used to treat Crohn's disease, antibiotic-associated diarrhea, and rosacea.
Mode of Action:
Metronidazole is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.
Metabolism:
Hepatic metabolism by hydroxylation, oxidation, and glucuronidation.
Toxicity:
LD50=500 mg/kg/day (orally in rat). Adverse effects include reversible peripheral neuropathy with prolonged therapy, CNS toxicity, disulfiram effect with alcohol, dark red-brown urine, metallic taste, nausea, epigastric distress, dizziness, vertigo and paresthesias associated with high doses, and neutropenia (reversible and mild).
General Reference:
Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG. 2006 Jan;113(1):65-74. PubmedLamont RF: Can antibiotics prevent preterm birth—the pro and con debate. BJOG. 2005 Mar;112 Suppl 1:67-73. PubmedWilliams CS, Woodcock KR: Do ethanol and metronidazole interact to produce a disulfiram-like reaction? Ann Pharmacother. 2000 Feb;34(2):255-7. PubmedVisapaa JP, Tillonen JS, Kaihovaara PS, Salaspuro MP: Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. Pubmed
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials

 

Related YouTube Videos